17-18118568-T-C

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_016239.4(MYO15A):​c.-219-14T>C variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.426 in 595,858 control chromosomes in the GnomAD database, including 60,889 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.46 ( 18096 hom., cov: 33)
Exomes 𝑓: 0.41 ( 42793 hom. )

Consequence

MYO15A
NM_016239.4 splice_polypyrimidine_tract, intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.962
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 17-18118568-T-C is Benign according to our data. Variant chr17-18118568-T-C is described in ClinVar as [Benign]. Clinvar id is 322102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.687 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYO15ANM_016239.4 linkuse as main transcriptc.-219-14T>C splice_polypyrimidine_tract_variant, intron_variant ENST00000647165.2 NP_057323.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkuse as main transcriptc.-219-14T>C splice_polypyrimidine_tract_variant, intron_variant NM_016239.4 ENSP00000495481 P1Q9UKN7-1

Frequencies

GnomAD3 genomes
AF:
0.463
AC:
70366
AN:
152016
Hom.:
18045
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.655
Gnomad AMI
AF:
0.417
Gnomad AMR
AF:
0.485
Gnomad ASJ
AF:
0.419
Gnomad EAS
AF:
0.635
Gnomad SAS
AF:
0.707
Gnomad FIN
AF:
0.415
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.322
Gnomad OTH
AF:
0.434
GnomAD4 exome
AF:
0.413
AC:
183388
AN:
443724
Hom.:
42793
Cov.:
5
AF XY:
0.428
AC XY:
99513
AN XY:
232494
show subpopulations
Gnomad4 AFR exome
AF:
0.667
Gnomad4 AMR exome
AF:
0.498
Gnomad4 ASJ exome
AF:
0.424
Gnomad4 EAS exome
AF:
0.657
Gnomad4 SAS exome
AF:
0.703
Gnomad4 FIN exome
AF:
0.382
Gnomad4 NFE exome
AF:
0.324
Gnomad4 OTH exome
AF:
0.417
GnomAD4 genome
AF:
0.463
AC:
70471
AN:
152134
Hom.:
18096
Cov.:
33
AF XY:
0.473
AC XY:
35186
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.655
Gnomad4 AMR
AF:
0.486
Gnomad4 ASJ
AF:
0.419
Gnomad4 EAS
AF:
0.636
Gnomad4 SAS
AF:
0.707
Gnomad4 FIN
AF:
0.415
Gnomad4 NFE
AF:
0.322
Gnomad4 OTH
AF:
0.433
Alfa
AF:
0.374
Hom.:
3596
Bravo
AF:
0.472
Asia WGS
AF:
0.662
AC:
2300
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 09, 2018- -
Autosomal recessive nonsyndromic hearing loss 3 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
17
DANN
Benign
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs854817; hg19: chr17-18021882; COSMIC: COSV52764452; COSMIC: COSV52764452; API